These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 1387511

  • 1. Generation of the neutrophil-activating peptide-2 by cathepsin G and cathepsin G-treated human platelets.
    Cohen AB, Stevens MD, Miller EJ, Atkinson MA, Mullenbach G.
    Am J Physiol; 1992 Aug; 263(2 Pt 1):L249-56. PubMed ID: 1387511
    [Abstract] [Full Text] [Related]

  • 2. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
    Car BD, Baggiolini M, Walz A.
    Biochem J; 1991 May 01; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
    [Abstract] [Full Text] [Related]

  • 3. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2.
    Härter L, Petersen F, Flad HD, Brandt E.
    J Immunol; 1994 Dec 15; 153(12):5698-708. PubMed ID: 7989767
    [Abstract] [Full Text] [Related]

  • 4. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein.
    Ehlert JE, Ludwig A, Grimm TA, Lindner B, Flad HD, Brandt E.
    Blood; 2000 Nov 01; 96(9):2965-72. PubMed ID: 11049972
    [Abstract] [Full Text] [Related]

  • 5. Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III.
    Brandt E, Van Damme J, Flad HD.
    Cytokine; 1991 Jul 01; 3(4):311-21. PubMed ID: 1873479
    [Abstract] [Full Text] [Related]

  • 6. Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G.
    Schiemann F, Grimm TA, Hoch J, Gross R, Lindner B, Petersen F, Bulfone-Paus S, Brandt E.
    Blood; 2006 Mar 15; 107(6):2234-42. PubMed ID: 16317101
    [Abstract] [Full Text] [Related]

  • 7. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.
    Ferrer-Lopez P, Renesto P, Schattner M, Bassot S, Laurent P, Chignard M.
    Am J Physiol; 1990 Jun 15; 258(6 Pt 1):C1100-7. PubMed ID: 2360620
    [Abstract] [Full Text] [Related]

  • 8. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
    Piccardoni P, Evangelista V, Piccoli A, de Gaetano G, Walz A, Cerletti C.
    Thromb Haemost; 1996 Nov 15; 76(5):780-5. PubMed ID: 8950790
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition by human leukocyte elastase of neutrophil-mediated platelet activation.
    Renesto P, Balloy V, Chignard M.
    Eur J Pharmacol; 1993 Aug 02; 248(2):151-5. PubMed ID: 8223961
    [Abstract] [Full Text] [Related]

  • 12. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
    Walz A, Dewald B, von Tscharner V, Baggiolini M.
    J Exp Med; 1989 Nov 01; 170(5):1745-50. PubMed ID: 2681518
    [Abstract] [Full Text] [Related]

  • 13. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
    Tralau T, Meyer-Hoffert U, Schröder JM, Wiedow O.
    Exp Dermatol; 2004 May 01; 13(5):316-25. PubMed ID: 15140022
    [Abstract] [Full Text] [Related]

  • 14. Neutrophil-activating intercrine secreted by porcine platelets is active without proteolytic processing.
    Yan Z, Holt JC, Stewart GJ, Niewiarowski S.
    Am J Physiol; 1993 Nov 01; 265(5 Pt 1):C1396-404. PubMed ID: 8238487
    [Abstract] [Full Text] [Related]

  • 15. Enhanced release of oxygen metabolites by monocyte-derived macrophages exposed to proteolytic enzymes: activity of neutrophil elastase and cathepsin G.
    Speer CP, Pabst MJ, Hedegaard HB, Rest RF, Johnston RB.
    J Immunol; 1984 Oct 01; 133(4):2151-6. PubMed ID: 6088632
    [Abstract] [Full Text] [Related]

  • 16. Ultrastructural changes of the skin induced by human leukocyte elastase and cathepsin G.
    Glinski W, Kuligowski M, Pierozynska-Dubowska M, Glinska-Ferenz M, Jablonska S.
    Acta Derm Venereol; 1991 Oct 01; 71(4):277-82. PubMed ID: 1681641
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets.
    Goel MS, Diamond SL.
    J Biol Chem; 2003 Mar 14; 278(11):9458-63. PubMed ID: 12524437
    [Abstract] [Full Text] [Related]

  • 19. Novel C-terminally truncated isoforms of the CXC chemokine beta-thromboglobulin and their impact on neutrophil functions.
    Ehlert JE, Gerdes J, Flad HD, Brandt E.
    J Immunol; 1998 Nov 01; 161(9):4975-82. PubMed ID: 9794434
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3.
    Padrines M, Wolf M, Walz A, Baggiolini M.
    FEBS Lett; 1994 Sep 26; 352(2):231-5. PubMed ID: 7925979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.